Consumer Healthcare Drug - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240694

Publication Date:

September 5, 2024

Pages:

122

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Consumer health products are听products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
The global market for Consumer Healthcare Drug was estimated to be worth US$ 125150 million in 2023 and is forecast to a readjusted size of US$ 182520 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Consumer Healthcare Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Consumer Healthcare Drug by region & country, by Type, and by Application.
The Consumer Healthcare Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Consumer Healthcare Drug.
麻豆原创 Segmentation
By Company
Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Segment by Type:
Solid Preparations
Oral Liquid
Patch
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Consumer Healthcare Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Consumer Healthcare Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Consumer Healthcare Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Consumer Healthcare Drug Product Introduction
1.2 Global Consumer Healthcare Drug 麻豆原创 Size Forecast
1.3 Consumer Healthcare Drug 麻豆原创 Trends & Drivers
1.3.1 Consumer Healthcare Drug Industry Trends
1.3.2 Consumer Healthcare Drug 麻豆原创 Drivers & Opportunity
1.3.3 Consumer Healthcare Drug 麻豆原创 Challenges
1.3.4 Consumer Healthcare Drug 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Consumer Healthcare Drug Players Revenue Ranking (2023)
2.2 Global Consumer Healthcare Drug Revenue by Company (2019-2024)
2.3 Key Companies Consumer Healthcare Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Consumer Healthcare Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Consumer Healthcare Drug
2.6 Consumer Healthcare Drug 麻豆原创 Competitive Analysis
2.6.1 Consumer Healthcare Drug 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Consumer Healthcare Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Consumer Healthcare Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solid Preparations
3.1.2 Oral Liquid
3.1.3 Patch
3.1.4 Other
3.2 Global Consumer Healthcare Drug Sales Value by Type
3.2.1 Global Consumer Healthcare Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Consumer Healthcare Drug Sales Value, by Type (2019-2030)
3.2.3 Global Consumer Healthcare Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Other
4.2 Global Consumer Healthcare Drug Sales Value by Application
4.2.1 Global Consumer Healthcare Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Consumer Healthcare Drug Sales Value, by Application (2019-2030)
4.2.3 Global Consumer Healthcare Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Consumer Healthcare Drug Sales Value by Region
5.1.1 Global Consumer Healthcare Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Consumer Healthcare Drug Sales Value by Region (2019-2024)
5.1.3 Global Consumer Healthcare Drug Sales Value by Region (2025-2030)
5.1.4 Global Consumer Healthcare Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Consumer Healthcare Drug Sales Value, 2019-2030
5.2.2 North America Consumer Healthcare Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Consumer Healthcare Drug Sales Value, 2019-2030
5.3.2 Europe Consumer Healthcare Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Consumer Healthcare Drug Sales Value, 2019-2030
5.4.2 Asia Pacific Consumer Healthcare Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Consumer Healthcare Drug Sales Value, 2019-2030
5.5.2 South America Consumer Healthcare Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Consumer Healthcare Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa Consumer Healthcare Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Consumer Healthcare Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Consumer Healthcare Drug Sales Value
6.3 United States
6.3.1 United States Consumer Healthcare Drug Sales Value, 2019-2030
6.3.2 United States Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Consumer Healthcare Drug Sales Value, 2019-2030
6.4.2 Europe Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Consumer Healthcare Drug Sales Value, 2019-2030
6.5.2 China Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Consumer Healthcare Drug Sales Value, 2019-2030
6.6.2 Japan Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Consumer Healthcare Drug Sales Value, 2019-2030
6.7.2 South Korea Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Consumer Healthcare Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Consumer Healthcare Drug Sales Value, 2019-2030
6.9.2 India Consumer Healthcare Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Consumer Healthcare Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Profile
7.1.2 Johnson & Johnson Main Business
7.1.3 Johnson & Johnson Consumer Healthcare Drug Products, Services and Solutions
7.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Johnson & Johnson Recent Developments
7.2 AbbVie
7.2.1 AbbVie Profile
7.2.2 AbbVie Main Business
7.2.3 AbbVie Consumer Healthcare Drug Products, Services and Solutions
7.2.4 AbbVie Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.2.5 AbbVie Recent Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Profile
7.3.2 Merck & Co. Main Business
7.3.3 Merck & Co. Consumer Healthcare Drug Products, Services and Solutions
7.3.4 Merck & Co. Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.3.5 GlaxoSmithKline Recent Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Profile
7.4.2 GlaxoSmithKline Main Business
7.4.3 GlaxoSmithKline Consumer Healthcare Drug Products, Services and Solutions
7.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.4.5 GlaxoSmithKline Recent Developments
7.5 Pfizer
7.5.1 Pfizer Profile
7.5.2 Pfizer Main Business
7.5.3 Pfizer Consumer Healthcare Drug Products, Services and Solutions
7.5.4 Pfizer Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer Recent Developments
7.6 Sanofi
7.6.1 Sanofi Profile
7.6.2 Sanofi Main Business
7.6.3 Sanofi Consumer Healthcare Drug Products, Services and Solutions
7.6.4 Sanofi Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Sanofi Recent Developments
7.7 Takeda
7.7.1 Takeda Profile
7.7.2 Takeda Main Business
7.7.3 Takeda Consumer Healthcare Drug Products, Services and Solutions
7.7.4 Takeda Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.7.5 Takeda Recent Developments
7.8 Bayer
7.8.1 Bayer Profile
7.8.2 Bayer Main Business
7.8.3 Bayer Consumer Healthcare Drug Products, Services and Solutions
7.8.4 Bayer Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Bayer Recent Developments
7.9 Teva
7.9.1 Teva Profile
7.9.2 Teva Main Business
7.9.3 Teva Consumer Healthcare Drug Products, Services and Solutions
7.9.4 Teva Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Teva Recent Developments
7.10 Sinopharm Group
7.10.1 Sinopharm Group Profile
7.10.2 Sinopharm Group Main Business
7.10.3 Sinopharm Group Consumer Healthcare Drug Products, Services and Solutions
7.10.4 Sinopharm Group Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Sinopharm Group Recent Developments
7.11 CR Pharmaceutical
7.11.1 CR Pharmaceutical Profile
7.11.2 CR Pharmaceutical Main Business
7.11.3 CR Pharmaceutical Consumer Healthcare Drug Products, Services and Solutions
7.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.11.5 CR Pharmaceutical Recent Developments
7.12 Shanghai Pharmaceuticals
7.12.1 Shanghai Pharmaceuticals Profile
7.12.2 Shanghai Pharmaceuticals Main Business
7.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Products, Services and Solutions
7.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.12.5 Shanghai Pharmaceuticals Recent Developments
7.13 Hualan Bio
7.13.1 Hualan Bio Profile
7.13.2 Hualan Bio Main Business
7.13.3 Hualan Bio Consumer Healthcare Drug Products, Services and Solutions
7.13.4 Hualan Bio Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.13.5 Hualan Bio Recent Developments
7.14 North China Pharmaceutical
7.14.1 North China Pharmaceutical Profile
7.14.2 North China Pharmaceutical Main Business
7.14.3 North China Pharmaceutical Consumer Healthcare Drug Products, Services and Solutions
7.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.14.5 North China Pharmaceutical Recent Developments
7.15 Hengrui Medicine
7.15.1 Hengrui Medicine Profile
7.15.2 Hengrui Medicine Main Business
7.15.3 Hengrui Medicine Consumer Healthcare Drug Products, Services and Solutions
7.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.15.5 Hengrui Medicine Recent Developments
7.16 Fosun Pharma
7.16.1 Fosun Pharma Profile
7.16.2 Fosun Pharma Main Business
7.16.3 Fosun Pharma Consumer Healthcare Drug Products, Services and Solutions
7.16.4 Fosun Pharma Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.16.5 Fosun Pharma Recent Developments
7.17 East China Medicine
7.17.1 East China Medicine Profile
7.17.2 East China Medicine Main Business
7.17.3 East China Medicine Consumer Healthcare Drug Products, Services and Solutions
7.17.4 East China Medicine Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.17.5 East China Medicine Recent Developments
7.18 Livzon Group
7.18.1 Livzon Group Profile
7.18.2 Livzon Group Main Business
7.18.3 Livzon Group Consumer Healthcare Drug Products, Services and Solutions
7.18.4 Livzon Group Consumer Healthcare Drug Revenue (US$ Million) & (2019-2024)
7.18.5 Livzon Group Recent Developments
8 Industry Chain Analysis
8.1 Consumer Healthcare Drug Industrial Chain
8.2 Consumer Healthcare Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Consumer Healthcare Drug Sales Model
8.5.2 Sales Channel
8.5.3 Consumer Healthcare Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.